Preclinical studies using adeno-associated virus vector–mediated delivery of the human PKP2 gene to PKP2-deficient mice prevented RV dilation, left ventricular functional decline, and reduced arrhythmia burden.9 This evidence concerns the gene PKP2 and Arrhythmia.